South Korean industrial conglomerate Samsung Electronics has tapped the head of its medical device business to also take over its Samsung Medison unit, according to published reports.
Jun Dong-soo has been named CEO of Samsung Medison, taking on the role in addition to his duties as chief executive of the medical equipment business, noted a March 10 article in the Korea Herald.
Jun takes over a position at the head of Samsung Medison that had been vacant since December 2015, when Cho Soo-in left the company. The vacancy led to speculation that Samsung was considering divesting the Medison division due to lower sales, according to the article.
Samsung bought a majority stake in Medison in 2010, but since then the company has lost its position as the largest Korean medical device maker and posted a net loss for the nine-month period of January to September 2015. Samsung in February denied that it was seeking to divest the division, Reuters reported.
The appointment of Jun to lead Samsung Medison puts one of Samsung's most respected executives at the helm of the unit, according to the Korea Herald.
This week at the Korea International Medical and Hospital Equipment Show (KIMES 2016) in Seoul, Jun met with reporters and talked positively about the veterinary market, for which Samsung is launched a new chemistry analyzer. He said the company plans to focus on its flagship ultrasound business.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
